Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer.
Authors
Priyadarshini Pathak
Massachusetts General Hospital, Boston, MA
Priyadarshini Pathak , Gerald Li , Julia Quintanilha , Rachel Beth Keller , Lincoln Pasquina , Julia Thierauf , Ryon Graf , Aparna Raj Parikh , Michael J. Pishvaian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 621)
DOI
10.1200/JCO.2024.42.3_suppl.621
Abstract #
621
Poster Bd #
J8
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Can stereotactic ablative radiotherapy for oligometastatic pancreatic cancer help avoid perpetual chemotherapy and improve outcomes?
First Author: Ahmed Elamir
Poster
2018 Gastrointestinal Cancers Symposium
Neutrophil-to-lymphocyte ratio as a prognostic marker for metastatic pancreatic cancer.
First Author: Jasmin Radhika Desai
Poster
2018 Gastrointestinal Cancers Symposium
The prognostic significance of exosomal markers (CD63 and CD9) expression using immunohistochemistry in patients with pancreatic ductal adenocarcinoma.
First Author: Moh'd M. Khushman
Poster
2017 Gastrointestinal Cancers Symposium
Impact of nab-paclitaxel-based second-line chemotherapy on the outcomes of pancreatic cancer.
First Author: Neelakanta Dadi